Dr. Luc Morris (IMAGE)

Memorial Sloan Kettering Cancer Center

Dr. Luc Morris

Caption

Dr. Luc Morris, a surgeon and research lab director at MSK, was the co-senior author of a research study to predict who will benefit from immune checkpoint inhibitors, a type of immunotherapy, using only routine blood tests and clinical data. The effort could make the treatment more accessible around the globe.

Credit

Memorial Sloan Kettering Cancer Center

Usage Restrictions

attribution

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.